Marta Molina-Alejandre

Marta Molina-Alejandre

Auto-generated profile, based on publicly available information

Marta Molina-Alejandre

Univ Complutense Madrid, Fac Med, Dept Inmunol Oftalmol & ORL, Madrid, Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2022 in Cellular Immunology
Verified
Journal Article
Open access
AAAna Aguinaga-Barrilero
Ana Aguinaga-Barrilero
IJIgnacio Juarez
Ignacio Juarez
CVChristian Vaquero-Yuste
Christian Vaquero-Yuste
MMMarta Molina-Alejandre
Marta Molina-Alejandre
AGAlberto Gutierrez-Calvo
Alberto Gutierrez-Calvo
JMJose Manuel Martin-Villa
Jose Manuel Martin-Villa
The presence of cells with regulatory functions in patients with cancer is one of the mechanisms whereby the immune system cannot confront tumor growth. We sought to determine the prevalence of immunoregulatory T -cell subpopulations, expressing the latency TGF beta-associated peptide (LAP), in patients with gastric adenocarcinoma.T cells were enriched from blood or gastric tissue (tumoral, TT or tumor-free, TF) samples from 22 patients, 6 with early (EGC) and 16 with advanced gastric cancer (AGC). CD4, CD8, LAP, FoxP3 and IFN-gamma were measured by cytometry.CD8 + LAP + cells were increased at tumoral sites, especially in early stages of the disease, as compared to tumor-free explants (EGC 5.28 % [4.67-6.64]*; AGC 2.90 % [1.37-4.44]; TF 3.14 % [2.33-4.16]; *p < 0.05 vs TF). Likewise, the LAP+/CD8 + LAP-ratio is increased in gastric samples from patients with early disease (EGC 0.38 [0.30-0.45]*, AGC 0.12 [0.07-0.14]; TF 0.12 [0.09-0.31]; *p < 0.05 vs AGC). Disease progression is accompanied by decreased LAP membrane expression and, probably, increased LAP secretion, therefore limiting the response to the tumor.

10 June 2021 in Biology
Verified
Journal Article
Open access
PDF file
IJIgnacio Juarez
Ignacio Juarez
JTJuan Toro-Fernandez
Juan Toro-Fernandez
CVChristian Vaquero-Yuste
Christian Vaquero-Yuste
MMMarta Molina-Alejandre
Marta Molina-Alejandre
ILInmaculada Lasa
Inmaculada Lasa
AGAlberto Gutierrez-Calvo
Alberto Gutierrez-Calvo
We have applied two PCR techniques, differential PCR (diffPCR) and qPCR for the identification of HER2 gene amplifications in genomic DNA of tumor and distal gastric samples from patients with gastric cancer. The diffPCR technique consists of the simultaneous amplification of the HER2 gene and a housekeeping gene by conventional PCR and the densitometric analysis of the bands obtained. We established a cut-off point based on the mean and standard deviation analyzing the DNA of 30 gastric tissues from patients undergoing non-cancer gastrectomy. diffPCR and qPCR yielded consistent results. HER2-overexpression was detected in 25% of patients and was further confirmed by immunohistochemistry and immunofluorescence. The approaches herein described may serve as complementary and reliable methods to assess HER2 amplification.